
Less than six months ago, no‐one had heard of COVID‐19 and few people knew what a coronavirus was, yet today it is on everyone's lips. On 11 March 2020, the WHO declared the outbreak a global pandemic, and the disease has spread to multiple countries across the globe. COVID‐19 is characterized by a fever, dry cough, fatigue and shortness of breath, and for the majority the symptoms will be minor; however, for a few, the illness can progress to pneumonia and multi‐organ failure. While data are emerging, it seems that the mortality rate is of the order of 1–2% [1]. So, what does the epidemic mean for people with diabetes?
SARS-CoV-2, Endocrinology, Diabetes and Metabolism, Pneumonia, Viral, COVID-19, Betacoronavirus, Endocrinology, Internal Medicine, Diabetes Mellitus, Humans, Coronavirus Infections, Pandemics, Behavioral Research
SARS-CoV-2, Endocrinology, Diabetes and Metabolism, Pneumonia, Viral, COVID-19, Betacoronavirus, Endocrinology, Internal Medicine, Diabetes Mellitus, Humans, Coronavirus Infections, Pandemics, Behavioral Research
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 132 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.1% |
